Pneumonia Due To Staphylococcus Aureus — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for pneumonia due to staphylococcus aureus. 20 active patents protecting 3 drugs from 3+ originators. First major cliff: 2027. Daily refresh.

3
Approved drugs
20
Active US patents
49/100
Avg vulnerability
—
Annual revenue covered

Originators in Pneumonia Due To Staphylococcus Aureus

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents AbbVie 4 patents Cumberland 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating pneumonia due to staphylococcus aureus. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
26
3
27
6
30
2
31
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Vibativ
TELAVANCIN HYDROCHLORIDE
 Cumberland 2 27 — 2027-01-01

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
8357394 Amoxil formulation 65 2026-12-08
9050263 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
7531623 Vibativ composition of matter 27 2027-01-01
7531623 Vibativ composition of matter 27 2027-01-01
10238606 Amoxil formulation 42 2034-02-12
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9050263 Amoxil method of use 62 2034-02-12

Related